MAIA logo

MAIA Biotechnology, Inc.

MAIA
Healthcare|Biotechnology|US
$1.06
+0.02 (+1.92%)
DCF Value
$269.53
Tangible Book / Share
$0.34
Cash / Share
$0.45
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Oct 7, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (6)

Mar 2027
Est. completion
NAFall Prevention
COMMUNITY-BASED POWER TRAINING IN FALLER AND NON-FALLER OLDER ADULTS: A FEASIBILITY AND FALL RISK STUDY.
NCT07369440n=120
Jun 2027
Est. completion
Early P1Chronic Pouchitis
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
NCT05829109n=16
Jul 2027
Est. completion
P3Carcinoma, Non-Small -Cell Lung
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
NCT06908304n=300
Sep 2027
Est. completion
P2Carcinoma, Non-Small-Cell Lung
THIO Sequenced With Cemiplimab in Advanced NSCLC
NCT05208944n=227
Sep 2029
Est. completion
Early P1Resectable Hepatocellular Carcinoma
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
NCT07446257n=60
Feb 2030
Est. completion
P2Pouchitis
Etrasimod as Prevention of Pouchitis
NCT07486921n=40

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Dec 2025
The Most Demanding Match Periods: Should GPS Data be Normalized
NCT07321496

Recent Press Releases

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
Oct 7, 2026 · GlobeNewsWire
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
Oct 1, 2026 · GlobeNewsWire
MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
Sep 23, 2026 · GlobeNewsWire
MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
Sep 22, 2026 · GlobeNewsWire
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
Sep 16, 2026 · GlobeNewsWire
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
Sep 15, 2026 · GlobeNewsWire
MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
Sep 10, 2026 · GlobeNewsWire
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
Aug 17, 2026 · GlobeNewsWire

SEC Filings (96)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 7, 2026424B3Offering prospectusDocumentIndex
Oct 6, 2026EFFECTDocumentIndex
Oct 6, 20268-KMaterial eventDocumentIndex
Oct 2, 2026424B3Offering prospectusDocumentIndex
Sep 25, 2026S-3Shelf registrationDocumentIndex
Aug 28, 2026EFFECTDocumentIndex
Aug 21, 2026S-3Shelf registrationDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 10, 202610-QQuarterly reportDocumentIndex
May 22, 20268-KMaterial eventDocumentIndex
May 19, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 14, 2026424B5Offering prospectusDocumentIndex
May 11, 202610-QQuarterly reportDocumentIndex
Apr 27, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Apr 8, 20268-KMaterial eventDocumentIndex
Apr 7, 2026S-8Employee stock planDocumentIndex
Apr 7, 2026ARSAnnual report to holdersDocumentIndex
Apr 7, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 7, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 2, 20268-KMaterial eventDocumentIndex
Mar 31, 20268-KMaterial eventDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 23, 202610-KAnnual reportDocumentIndex
Mar 4, 20268-KMaterial eventDocumentIndex
Mar 4, 2026424B5Offering prospectusDocumentIndex
Mar 2, 2026424B5Offering prospectusDocumentIndex
Feb 24, 20268-KMaterial eventDocumentIndex
Jan 20, 20268-KMaterial eventDocumentIndex
Jan 13, 20268-KMaterial eventDocumentIndex
Jan 5, 2026DDocumentIndex
Dec 17, 20258-KMaterial eventDocumentIndex
Dec 11, 20258-KMaterial eventDocumentIndex
Dec 10, 20258-KMaterial eventDocumentIndex
Dec 4, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 21, 20258-KMaterial eventDocumentIndex
Nov 20, 20258-KMaterial eventDocumentIndex
Nov 7, 202510-QQuarterly reportDocumentIndex